These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8598575

  • 1. H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice.
    Manjanatha MG, Li EE, Fu PP, Heflich RH.
    J Toxicol Environ Health; 1996 Feb 09; 47(2):195-208. PubMed ID: 8598575
    [Abstract] [Full Text] [Related]

  • 2. Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl/10J mouse liver tumours.
    Lord PG, Hardaker KJ, Loughlin JM, Marsden AM, Orton TC.
    Carcinogenesis; 1992 Aug 09; 13(8):1383-7. PubMed ID: 1499088
    [Abstract] [Full Text] [Related]

  • 3. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T, Reynolds S, Maronpot R, Anderson M.
    Cancer Res; 1990 Aug 01; 50(15):4818-23. PubMed ID: 2196119
    [Abstract] [Full Text] [Related]

  • 4. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
    Hegi ME, Fox TR, Belinsky SA, Devereux TR, Anderson MW.
    Carcinogenesis; 1993 Jan 01; 14(1):145-9. PubMed ID: 8425263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
    Chen B, Liu L, Castonguay A, Maronpot RR, Anderson MW, You M.
    Carcinogenesis; 1993 Aug 01; 14(8):1603-8. PubMed ID: 8353844
    [Abstract] [Full Text] [Related]

  • 7. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y, Wang Y, Stoner G, You M.
    Cancer Res; 1993 Apr 01; 53(7):1620-4. PubMed ID: 8453632
    [Abstract] [Full Text] [Related]

  • 8. Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin.
    Wang Y, Gao D, Atencio DP, Perez E, Saladi R, Moore J, Guevara D, Rosenstein BS, Lebwohl M, Wei H.
    Int J Cancer; 2005 Aug 20; 116(2):193-9. PubMed ID: 15800929
    [Abstract] [Full Text] [Related]

  • 9. Tumorigenicity and liver tumor ras-protooncogene mutations in CD-1 mice treated neonatally with 1- and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol and aminobenzo[a]pyrene metabolites.
    Von Tungeln LS, Xia Q, Bucci T, Heflich RH, Fu PP.
    Cancer Lett; 1999 Apr 01; 137(2):137-43. PubMed ID: 10374834
    [Abstract] [Full Text] [Related]

  • 10. Relationships of DNA adduct formation, K-ras activating mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice.
    Li EE, Heflich RH, Bucci TJ, Manjanatha MG, Blaydes BS, Delclos KB.
    Carcinogenesis; 1994 Jul 01; 15(7):1377-85. PubMed ID: 8033314
    [Abstract] [Full Text] [Related]

  • 11. Ras mutations in methylclofenapate-induced B6C3F1 and C57BL/10J mouse liver tumours.
    Stanley LA, Blackburn DR, Devereaux S, Foley J, Lord PG, Maronpot RR, Orton TC, Anderson MW.
    Carcinogenesis; 1994 Jun 01; 15(6):1125-31. PubMed ID: 8020144
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S, Storer RD, Prahalada S, Leander KR, Kraynak AR, Ledwith BJ, van Zwieten MJ, Bradley MO, Nichols WW.
    Cancer Res; 1992 Jun 15; 52(12):3347-52. PubMed ID: 1596892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.
    Stanley LA, Devereux TR, Foley J, Lord PG, Maronpot RR, Orton TC, Anderson MW.
    Carcinogenesis; 1992 Dec 15; 13(12):2427-33. PubMed ID: 1361883
    [Abstract] [Full Text] [Related]

  • 17. Tumorigenicity of nitropolycyclic aromatic hydrocarbons in the neonatal B6C3F1 mouse bioassay and characterization of ras mutations in liver tumors from treated mice.
    Von Tungeln LS, Xia Q, Herreno-Saenz D, Bucci TJ, Heflich RH, Fu PP.
    Cancer Lett; 1999 Nov 01; 146(1):1-7. PubMed ID: 10656603
    [Abstract] [Full Text] [Related]

  • 18. Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency.
    Parsons BL, Delongchamp RR, Beland FA, Heflich RH.
    Mutagenesis; 2006 Jan 01; 21(1):29-34. PubMed ID: 16314341
    [Abstract] [Full Text] [Related]

  • 19. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
    Buchmann A, Bauer-Hofmann R, Mahr J, Drinkwater NR, Luz A, Schwarz M.
    Proc Natl Acad Sci U S A; 1991 Feb 01; 88(3):911-5. PubMed ID: 1992483
    [Abstract] [Full Text] [Related]

  • 20. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
    Buchmann A, Karcier Z, Schmid B, Strathmann J, Schwarz M.
    Mutat Res; 2008 Feb 01; 638(1-2):66-74. PubMed ID: 17928010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.